Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
VCEL.OQ - Vericel Corporation
Vericel Corporation at Morgan Stanley Global Healthcare Conference
Sep 15, 2026 / 06:35PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you very much. This is Peter Harrison from Morgan Stanley's Investment Banking Group. I'd like to welcome you to the VeraCell Chat. Today with us is Nick Colangelo, the CEO, and Joe Mara, the CFO.
With that, we'll get started.
Thank you very much for attending the conference. We greatly appreciate it. Happy to be here.
Thank you. Thanks for having us. Let's start with Macy, of course. It's your lead product for cartilage repair on the knee. TAM is $4 billion in the US. You're currently preparing to launch it outside the US and conducting a trial for the product and the ankle. Can you provide an update on these two initiatives and how they will continue to drive what's been an
Trustpilot
